You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/03/21 | 8-K | Current report filing |
|
   |
44 |
| 09/03/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
40 | |
| 08/19/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/17/21 | 8-K | Current report filing |
|
|
3 |
| 08/16/21 | 8-K | Current report filing |
|
|
5 |
| 08/12/21 | 8-K | Current report filing |
|
|
12 |
| 08/12/21 | 8-K | Current report filing |
|
|
10 |
| 08/11/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
88 |
| 08/03/21 | EFFECT | Notice of Effectiveness |
|
1 | |
| 08/03/21 | S-3/A | Registration statement for specified transactions by certain issuers |
|
7 |
